Airway hyperresponsiveness: New insights into the pathogenesis

Seminars in Respiratory and Critical Care Medicine

Volumn 33, Issue 6, 2012, Pages 579-587

  Lommatzsch, Marek ^a  

^a UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

airway hyperresponsiveness; asthma; inflammation; nerves; smooth muscle

Indexed keywords

ALLERGEN; ANTIINFLAMMATORY AGENT; CHOLINERGIC RECEPTOR BLOCKING AGENT; HISTAMINE; IMMUNOGLOBULIN E; METHACHOLINE;

ARTICLE; ASTHMA; BRONCHUS MUSCLE; COMORBIDITY; DENDRITIC CELL; EOSINOPHIL; EXTRACELLULAR MATRIX; FORCED EXPIRATORY VOLUME; HUMAN; IMMUNOGLOBULIN PRODUCTION; LUNG VOLUME; MAST CELL; NERVE CELL; NONHUMAN; OBESITY; PRIORITY JOURNAL; PROVOCATION TEST; RESPIRATORY EPITHELIUM; RESPIRATORY TRACT ALLERGY; SMOOTH MUSCLE FIBER; SMOOTH MUSCLE TONE; T LYMPHOCYTE; TH2 CELL;

ANIMALS; ANTI-INFLAMMATORY AGENTS; ASTHMA; BRONCHIAL HYPERREACTIVITY; DRUG DESIGN; HUMANS; INFLAMMATION; MYOCYTES, SMOOTH MUSCLE; OBESITY; SEVERITY OF ILLNESS INDEX;

EID: 84867063485     PISSN: 10693424     EISSN: 10989048     Source Type: Journal    
DOI: 10.1055/s-0032-1325617     Document Type: Article

References (125)

1. Lemanske R. F. Jr, Busse W. W. Asthma: clinical expression and molecular mechanisms. J Allergy Clin Immunol: 2010; 125 2, Suppl 2 S95 S102
2. Larj M. J., Bleecker E. R. Therapeutic responses in asthma and COPD. Corticosteroids. Chest: 2004; 126 2, Suppl 138S 149S, discussion 159S-161S (Pubitemid 39093403)
3. Koskela H. O., Hyvärinen L., Brannan J. D., Chan H. K., Anderson S. D. Sensitivity and validity of three bronchial provocation tests to demonstrate the effect of inhaled corticosteroids in asthma. Chest: 2003; 124 4 1341 1349 (Pubitemid 37290044)
4. Erin E. M., Zacharasiewicz A. S., Nicholson G. C., et al. Rapid effect of inhaled ciclesonide in asthma: a randomized, placebo-controlled study. Chest: 2008; 134 4 740 745
5. Busse W. W., Lemanske R. F. Jr. Asthma. N Engl J Med: 2001; 344 5 350 362 (Pubitemid 32107645)
6. Cockcroft D. W., Davis B. E. Mechanisms of airway hyperresponsiveness. J Allergy Clin Immunol: 2006; 118 3 551 559, quiz 560-561 (Pubitemid 44301418)
7. Leckie M. J., ten Brinke A., Khan J., et al. Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsiveness, and the late asthmatic response. Lancet: 2000; 356 9248 2144 2148
8. Haldar P., Brightling C. E., Hargadon B., et al. Mepolizumab and exacerbations of refractory eosinophilic asthma. N Engl J Med: 2009; 360 10 973 984
9. Pauwels R., Joos G., Van der Straeten M. Bronchial hyperresponsiveness is not bronchial hyperresponsiveness is not bronchial asthma. Clin Allergy: 1988; 18 4 317 321
10. Cockcroft D. W. Direct challenge tests: airway hyperresponsiveness in asthma: its measurement and clinical significance. Chest: 2010; 138 2, Suppl 18S 24S
11. Anderson S. D. Indirect challenge tests: airway hyperresponsiveness in asthma: its measurement and clinical significance. Chest: 2010; 138 2, Suppl 25S 30S
12. Lommatzsch M., Schloetcke K., Klotz J., et al. Brain-derived neurotrophic factor in platelets and airflow limitation in asthma. Am J Respir Crit Care Med: 2005; 171 2 115 120 (Pubitemid 40105409)
13. Koskela H. O., Hyvärinen L., Brannan J. D., Chan H. K., Anderson S. D. Responsiveness to three bronchial provocation tests in patients with asthma. Chest: 2003; 124 6 2171 2177 (Pubitemid 38010586)
14. Bakirtas A., Turktas I. Methacholine and adenosine 5-monophosphate challenges in preschool children with cough-variant and classic asthma. Pediatr Pulmonol: 2007; 42 10 973 979 (Pubitemid 47549805)
15. Suh D. I., Lee J. K., Kim C. K., Koh Y. Y. Bronchial hyperresponsiveness to methacholine and adenosine 5-monophosphate, and the presence and degree of atopy in young children with asthma. Clin Exp Allergy: 2011; 41 3 338 345
16. Sylvester K. P., O'Connor B. J., Farebrother H. M., Rafferty G. F., Greenough A. Cold air and exercise challengeinfluence of minute ventilation. J Asthma: 2007; 44 2 143 147 (Pubitemid 46439698)
17. Grainge C. L., Lau L. C., Ward J. A., et al. Effect of bronchoconstriction on airway remodeling in asthma. N Engl J Med: 2011; 364 21 2006 2015
18. Gern J. E. Barnyard microbes and childhood asthma. N Engl J Med: 2011; 364 8 769 770
19. Ege M. J., Mayer M., Normand A. C., et al. GABRIELA Transregio 22 Study Group Exposure to environmental microorganisms and childhood asthma. N Engl J Med: 2011; 364 8 701 709
20. Holgate S. T. The sentinel role of the airway epithelium in asthma pathogenesis. Immunol Rev: 2011; 242 1 205 219
21. Al-Muhsen S., Johnson J. R., Hamid Q. Remodeling in asthma. J Allergy Clin Immunol: 2011; 128 3 451 462, quiz 463-464
22. Nakao A., Sagara H., Setoguchi Y., et al. Expression of Smad7 in bronchial epithelial cells is inversely correlated to basement membrane thickness and airway hyperresponsiveness in patients with asthma. J Allergy Clin Immunol: 2002; 110 6 873 878 (Pubitemid 36005874)
23. Hahn C., Islamian A. P., Renz H., Nockher W. A. Airway epithelial cells produce neurotrophins and promote the survival of eosinophils during allergic airway inflammation. J Allergy Clin Immunol: 2006; 117 4 787 794
24. Sidhu S. S., Yuan S., Innes A. L., et al. Roles of epithelial cell-derived periostin in TGF-beta activation, collagen production, and collagen gel elasticity in asthma. Proc Natl Acad Sci U S A: 2010; 107 32 14170 14175
25. Halwani R., Al-Abri J., Beland M., et al. CC and CXC chemokines induce airway smooth muscle proliferation and survival. J Immunol: 2011; 186 7 4156 4163
26. Lambrecht B. N., Hammad H. The role of dendritic and epithelial cells as master regulators of allergic airway inflammation. Lancet: 2010; 376 9743 835 843
27. Lambrecht B. N., Hammad H. Biology of lung dendritic cells at the origin of asthma. Immunity: 2009; 31 3 412 424
28. Lambrecht B. N., Hammad H. Taking our breath away: dendritic cells in the pathogenesis of asthma. Nat Rev Immunol: 2003; 3 12 994 1003 (Pubitemid 37521541)
29. van Rijt L. S., Vos N., Willart M., et al. Persistent activation of dendritic cells after resolution of allergic airway inflammation breaks tolerance to inhaled allergens in mice. Am J Respir Crit Care Med: 2011; 184 3 303 311
30. Bratke K., Lommatzsch M., Julius P., et al. Dendritic cell subsets in human bronchoalveolar lavage fluid after segmental allergen challenge. Thorax: 2007; 62 2 168 175
31. Dreschler K., Bratke K., Petermann S., et al. Impact of immunotherapy on blood dendritic cells in patients with Hymenoptera venom allergy. J Allergy Clin Immunol: 2011; 127 2 487 494, e1-e3
32. Lambrecht B. N. Lung dendritic cells: targets for therapy in allergic disease. Curr Mol Med: 2008; 8 5 393 400
33. Robinson D. S. The role of the T cell in asthma. J Allergy Clin Immunol: 2010; 126 6 1081 1091, quiz 1092-1093
34. Lloyd C. M., Hawrylowicz C. M. Regulatory T cells in asthma. Immunity: 2009; 31 3 438 449
35. Hartl D., Koller B., Mehlhorn A. T., et al. Quantitative and functional impairment of pulmonary CD4+ CD25hi regulatory T cells in pediatric asthma. J Allergy Clin Immunol: 2007; 119 5 1258 1266 (Pubitemid 46654192)
36. Akbari O., Faul J. L., Hoyte E. G., et al. CD4+ invariant T-cell-receptor+ natural killer T cells in bronchial asthma. N Engl J Med: 2006; 354 11 1117 1129
37. Vijayanand P., Seumois G., Pickard C., et al. Invariant natural killer T cells in asthma and chronic obstructive pulmonary disease. N Engl J Med: 2007; 356 14 1410 1422 (Pubitemid 46556326)
38. Thomas S. Y., Chyung Y. H., Luster A. D. Natural killer T cells are not the predominant T cell in asthma and likely modulate, not cause, asthma. J Allergy Clin Immunol: 2010; 125 5 980 984
39. Bratke K., Julius P., Virchow J. C. Invariant natural killer T cells in obstructive pulmonary diseases. N Engl J Med: 2007; 357 2 194, author reply 194-195 (Pubitemid 47057750)
40. Wenzel S., Holgate S. T. The mouse trap: it still yields few answers in asthma. Am J Respir Crit Care Med: 2006; 174 11 1173 1176, discussion 1176-1178 (Pubitemid 44924815)
41. Lommatzsch M., Julius P., Kuepper M., et al. The course of allergen-induced leukocyte infiltration in human and experimental asthma. J Allergy Clin Immunol: 2006; 118 1 91 97 (Pubitemid 43946466)
42. Lommatzsch M., Julius P., Virchow J. C. Mice running late: T-cell kinetics in models of asthma. Am J Respir Crit Care Med: 2007; 175 5 522b 523
43. Corren J. Cytokine inhibition in severe asthma: current knowledge and future directions. Curr Opin Pulm Med: 2011; 17 1 29 33
44. Holgate S., Smith N., Massanari M., Jimenez P. Effects of omalizumab on markers of inflammation in patients with allergic asthma. Allergy: 2009; 64 12 1728 1736
45. Holgate S., Buhl R., Bousquet J., Smith N., Panahloo Z., Jimenez P. The use of omalizumab in the treatment of severe allergic asthma: a clinical experience update. Respir Med: 2009; 103 8 1098 1113
46. Busse W. W., Morgan W. J., Gergen P. J., et al. Randomized trial of omalizumab (anti-IgE) for asthma in inner-city children. N Engl J Med: 2011; 364 11 1005 1015
47. Nair P., Pizzichini M. M., Kjarsgaard M., et al. Mepolizumab for prednisone-dependent asthma with sputum eosinophilia. N Engl J Med: 2009; 360 10 985 993
48. Tomkinson A., Tepper J., Morton M., et al. Inhaled vs subcutaneous effects of a dual IL-4/IL-13 antagonist in a monkey model of asthma. Allergy: 2010; 65 1 69 77
49. Corren J., Lemanske R. F., Hanania N. A., et al. Lebrikizumab treatment in adults with asthma. N Engl J Med: 2011; 365 12 1088 1098
50. Dougherty R. H., Sidhu S. S., Raman K., et al. Accumulation of intraepithelial mast cells with a unique protease phenotype in T(H)2-high asthma. J Allergy Clin Immunol: 2010; 125 5 1046 1053, e8
51. Bradding P., Walls A. F., Holgate S. T. The role of the mast cell in the pathophysiology of asthma. J Allergy Clin Immunol: 2006; 117 6 1277 1284 (Pubitemid 43795741)
52. Ito A., Hagiyama M., Oonuma J. Nerve-mast cell and smooth muscle-mast cell interaction mediated by cell adhesion molecule-1, CADM1. J Smooth Muscle Res: 2008; 44 2 83 93
53. Brightling C. E., Bradding P. The re-emergence of the mast cell as a pivotal cell in asthma pathogenesis. Curr Allergy Asthma Rep: 2005; 5 2 130 135 (Pubitemid 40331069)
54. Siddiqui S., Mistry V., Doe C., et al. Airway hyperresponsiveness is dissociated from airway wall structural remodeling. J Allergy Clin Immunol: 2008; 122 2 335 341, 341, e1-e3
55. Graff-Lonnevig V., Hedlin G. The effect of ketotifen on bronchial hyperreactivity in childhood asthma. J Allergy Clin Immunol: 1985; 76 1 59 63 (Pubitemid 15230550)
56. Holgate S. T., Noonan M., Chanez P., et al. Efficacy and safety of etanercept in moderate-to-severe asthma: a randomised, controlled trial. Eur Respir J: 2011; 37 6 1352 1359
57. Bush A., Zar H. J. WHO universal definition of severe asthma. Curr Opin Allergy Clin Immunol: 2011; 11 2 115 121
58. Pascual R. M., Peters S. P. The irreversible component of persistent asthma. J Allergy Clin Immunol: 2009; 124 5 883 890, quiz 891-892
59. Proskocil B. J., Fryer A. D. Beta2-agonist and anticholinergic drugs in the treatment of lung disease. Proc Am Thorac Soc: 2005; 2 4 305 310, discussion 311-312 (Pubitemid 41566940)
60. Canning B. J., Fischer A. Neural regulation of airway smooth muscle tone. Respir Physiol: 2001; 125 1-2 113 127 (Pubitemid 32184648)
61. Felder C. C. Muscarinic acetylcholine receptors: signal transduction through multiple effectors. FASEB J: 1995; 9 8 619 625
62. Kummer W., Lips K. S., Pfeil U. The epithelial cholinergic system of the airways. Histochem Cell Biol: 2008; 130 2 219 234
63. Barnes P. J. Overview of neural mechanisms in asthma. Pulm Pharmacol: 1995; 8 4-5 151 159 (Pubitemid 26171156)
64. Lommatzsch M., Virchow J. C. The neural underpinnings of asthma. J Allergy Clin Immunol: 2007; 119 1 254 255, author reply 255 (Pubitemid 46037816)
65. Undem B. J., Carr M. J. The role of nerves in asthma. Curr Allergy Asthma Rep: 2002; 2 2 159 165
66. Lommatzsch M., Braun A., Renz H. Neurotrophins in allergic airway dysfunction: what the mouse model is teaching us. Ann N Y Acad Sci: 2003; 992 241 249 (Pubitemid 36706652)
67. Verhein K. C., Fryer A. D., Jacoby D. B. Neural control of airway inflammation. Curr Allergy Asthma Rep: 2009; 9 6 484 490
68. Fryer A. D., Stein L. H., Nie Z., et al. Neuronal eotaxin and the effects of CCR3 antagonist on airway hyperreactivity and M2 receptor dysfunction. J Clin Invest: 2006; 116 1 228 236 (Pubitemid 43121808)
69. Huang E. J., Reichardt L. F. Neurotrophins: roles in neuronal development and function. Annu Rev Neurosci: 2001; 24 677 736 (Pubitemid 32695243)
70. Prakash Y., Thompson M. A., Meuchel L., et al. Neurotrophins in lung health and disease. Expert Rev Respir Med: 2010; 4 3 395 411
71. Lommatzsch M., Zingler D., Schuhbaeck K., et al. The impact of age, weight and gender on BDNF levels in human platelets and plasma. Neurobiol Aging: 2005; 26 1 115 123 (Pubitemid 39600596)
72. Fujimura H., Altar C. A., Chen R., et al. Brain-derived neurotrophic factor is stored in human platelets and released by agonist stimulation. Thromb Haemost: 2002; 87 4 728 734 (Pubitemid 34302963)
73. Braun A., Lommatzsch M., Mannsfeldt A., et al. Cellular sources of enhanced brain-derived neurotrophic factor production in a mouse model of allergic inflammation. Am J Respir Cell Mol Biol: 1999; 21 4 537 546 (Pubitemid 129504276)
74. Braun A., Lommatzsch M., Neuhaus-Steinmetz U., et al. Brain-derived neurotrophic factor (BDNF) contributes to neuronal dysfunction in a model of allergic airway inflammation. Br J Pharmacol: 2004; 141 3 431 440 (Pubitemid 38297006)
75. Bennedich Kahn L., Gustafsson L. E., Olgart Höglund C. Brain-derived neurotrophic factor enhances histamine-induced airway responses and changes levels of exhaled nitric oxide in guinea pigs in vivo. Eur J Pharmacol: 2008; 595 1-3 78 83
76. Prakash Y. S., Thompson M. A., Pabelick C. M. Brain-derived neurotrophic factor in TNF-alpha modulation of Ca2+ in human airway smooth muscle. Am J Respir Cell Mol Biol: 2009; 41 5 603 611
77. Aravamudan B., Thompson M., Pabelick C., Prakash Y. S. Brain derived neurotrophic factor induces proliferation of human airway smooth muscle cells. J Cell Mol Med: 2012; 16 4 812 823
78. Meuchel L. W., Stewart A., Smelter D. F., et al. Neurokinin-neurotrophin interactions in airway smooth muscle. Am J Physiol Lung Cell Mol Physiol: 2011; 301 1 L91 L98
79. Virchow J. C., Julius P., Lommatzsch M., Luttmann W., Renz H., Braun A. Neurotrophins are increased in bronchoalveolar lavage fluid after segmental allergen provocation. Am J Respir Crit Care Med: 1998; 158 6 2002 2005 (Pubitemid 29008846)
80. Kornerup K. N., Page C. P. The role of platelets in the pathophysiology of asthma. Platelets: 2007; 18 5 319 328 (Pubitemid 47123838)
81. Pitchford S. C., Momi S., Baglioni S., et al. Allergen induces the migration of platelets to lung tissue in allergic asthma. Am J Respir Crit Care Med: 2008; 177 6 604 612 (Pubitemid 351442167)
82. Lommatzsch M., Lindner Y., Edner A., Bratke K., Kuepper M., Virchow J. C. Adverse effects of salmeterol in asthma: a neuronal perspective. Thorax: 2009; 64 9 763 769
83. Cazorla M., Prémont J., Mann A., Girard N., Kellendonk C., Rognan D. Identification of a low-molecular weight TrkB antagonist with anxiolytic and antidepressant activity in mice. J Clin Invest: 2011; 121 5 1846 1857
84. Eibl J. K., Chapelsky S. A., Ross G. M. Multipotent neurotrophin antagonist targets brain-derived neurotrophic factor and nerve growth factor. J Pharmacol Exp Ther: 2010; 332 2 446 454
85. Stoll P., Plessow A., Bratke K., Virchow J. C., Lommatzsch M. Differential effect of clopidogrel and aspirin on the release of BDNF from platelets. J Neuroimmunol: 2011; 238 1-2 104 106
86. Ramalho R., Soares R., Couto N., Moreira A. Tachykinin receptors antagonism for asthma: a systematic review. BMC Pulm Med: 2011; 11 41
87. Caceres A. I., Brackmann M., Elia M. D., et al. A sensory neuronal ion channel essential for airway inflammation and hyperreactivity in asthma. Proc Natl Acad Sci U S A: 2009; 106 22 9099 9104
88. Grace M. S., Belvisi M. G. TRPA1 receptors in cough. Pulm Pharmacol Ther: 2011; 24 3 286 288
89. Bara I., Ozier A., Tunon de Lara J. M., Marthan R., Berger P. Pathophysiology of bronchial smooth muscle remodelling in asthma. Eur Respir J: 2010; 36 5 1174 1184
90. Dekkers B. G., Maarsingh H., Meurs H., Gosens R. Airway structural components drive airway smooth muscle remodeling in asthma. Proc Am Thorac Soc: 2009; 6 8 683 692
91. An S. S., Bai T. R., Bates J. H., et al. Airway smooth muscle dynamics: a common pathway of airway obstruction in asthma. Eur Respir J: 2007; 29 5 834 860 (Pubitemid 46722226)
92. Oliver M. N., Fabry B., Marinkovic A., Mijailovich S. M., Butler J. P., Fredberg J. J. Airway hyperresponsiveness, remodeling, and smooth muscle mass: right answer, wrong reason? Am J Respir Cell Mol Biol: 2007; 37 3 264 272 (Pubitemid 350067606)
93. James A. L., Bai T. R., Mauad T., et al. Airway smooth muscle thickness in asthma is related to severity but not duration of asthma. Eur Respir J: 2009; 34 5 1040 1045
94. Araujo B. B., Dolhnikoff M., Silva L. F., et al. Extracellular matrix components and regulators in the airway smooth muscle in asthma. Eur Respir J: 2008; 32 1 61 69
95. Woodruff P. G., Dolganov G. M., Ferrando R. E., et al. Hyperplasia of smooth muscle in mild to moderate asthma without changes in cell size or gene expression. Am J Respir Crit Care Med: 2004; 169 9 1001 1006 (Pubitemid 38543637)
96. Benayoun L., Druilhe A., Dombret M. C., Aubier M., Pretolani M. Airway structural alterations selectively associated with severe asthma. Am J Respir Crit Care Med: 2003; 167 10 1360 1368 (Pubitemid 36609720)
97. Ma X., Cheng Z., Kong H., et al. Changes in biophysical and biochemical properties of single bronchial smooth muscle cells from asthmatic subjects. Am J Physiol Lung Cell Mol Physiol: 2002; 283 6 L1181 L1189 (Pubitemid 35379249)
98. Brightling C. E., Bradding P., Symon F. A., Holgate S. T., Wardlaw A. J., Pavord I. D. Mast-cell infiltration of airway smooth muscle in asthma. N Engl J Med: 2002; 346 22 1699 1705 (Pubitemid 34547483)
99. Brightling C. E., Ammit A. J., Kaur D., et al. The CXCL10/CXCR3 axis mediates human lung mast cell migration to asthmatic airway smooth muscle. Am J Respir Crit Care Med: 2005; 171 10 1103 1108 (Pubitemid 40663721)
100. Gosens R., Roscioni S. S., Dekkers B. G., et al. Pharmacology of airway smooth muscle proliferation. Eur J Pharmacol: 2008; 585 2-3 385 397
101. Gosens R., Zaagsma J., Grootte Bromhaar M., Nelemans A., Meurs H. Acetylcholine: a novel regulator of airway smooth muscle remodelling? Eur J Pharmacol: 2004; 500 1-3 193 201 (Pubitemid 39304008)
102. Durrani S. R., Viswanathan R. K., Busse W. W. What effect does asthma treatment have on airway remodeling? Current perspectives. J Allergy Clin Immunol: 2011; 128 3 439 448, quiz 449-450
103. Peters S. P., Kunselman S. J., Icitovic N., et al. National Heart, Lung, and Blood Institute Asthma Clinical Research Network Tiotropium bromide step-up therapy for adults with uncontrolled asthma. N Engl J Med: 2010; 363 18 1715 1726
104. Cox G., Thomson N. C., Rubin A. S., et al. AIR Trial Study Group Asthma control during the year after bronchial thermoplasty. N Engl J Med: 2007; 356 13 1327 1337 (Pubitemid 46513298)
105. Castro M., Rubin A. S., Laviolette M., et al. AIR2 Trial Study Group Effectiveness and safety of bronchial thermoplasty in the treatment of severe asthma: a multicenter, randomized, double-blind, sham-controlled clinical trial. Am J Respir Crit Care Med: 2010; 181 2 116 124
106. Thomson N. C., Rubin A. S., Niven R. M., et al. AIR Trial Study Group Long-term (5 year) safety of bronchial thermoplasty: Asthma Intervention Research (AIR) trial. BMC Pulm Med: 2011; 11 8
107. Corren J. Small airways disease in asthma. Curr Allergy Asthma Rep: 2008; 8 6 533 539
108. Salerno F. G., Barbaro M. P., Toungoussova O., Carpagnano E., Guido P., Spanevello A. The extracellular matrix of the lung and airway responsiveness in asthma. Monaldi Arch Chest Dis: 2009; 71 1 27 30
109. Pini L., Hamid Q., Shannon J., et al. Differences in proteoglycan deposition in the airways of moderate and severe asthmatics. Eur Respir J: 2007; 29 1 71 77 (Pubitemid 46092000)
110. An S. S., Fredberg J. J. Biophysical basis for airway hyperresponsiveness. Can J Physiol Pharmacol: 2007; 85 7 700 714 (Pubitemid 350033268)
111. Park H. S., Kim S. Y., Kim S. R., Lee Y. C. Targeting abnormal airway vascularity as a therapeutical strategy in asthma. Respirology: 2010; 15 3 459 471
112. Detoraki A., Granata F., Staibano S., Rossi F. W., Marone G., Genovese A. Angiogenesis and lymphangiogenesis in bronchial asthma. Allergy: 2010; 65 8 946 958
113. Zanini A., Chetta A., Imperatori A. S., Spanevello A., Olivieri D. The role of the bronchial microvasculature in the airway remodelling in asthma and COPD. Respir Res: 2010; 11 132
114. Finucane M. M., Stevens G. A., Cowan M. J., et al. Global Burden of Metabolic Risk Factors of Chronic Diseases Collaborating Group (Body Mass Index) National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9·1 million participants. Lancet: 2011; 377 9765 557 567
115. Kelly T., Yang W., Chen C. S., Reynolds K., He J. Global burden of obesity in 2005 and projections to 2030. Int J Obes (Lond): 2008; 32 9 1431 1437
116. Shore S. A. Obesity and asthma: possible mechanisms. J Allergy Clin Immunol: 2008; 121 5 1087 1093, quiz 1094-1095
117. Shore S. A., Johnston R. A. Obesity and asthma. Pharmacol Ther: 2006; 110 1 83 102 (Pubitemid 43248727)
118. Ding D. J., Martin J. G., Macklem P. T. Effects of lung volume on maximal methacholine-induced bronchoconstriction in normal humans. J Appl Physiol: 1987; 62 3 1324 1330 (Pubitemid 17073939)
119. Boulet L. P., Turcotte H., Boulet G., Simard B., Robichaud P. Deep inspiration avoidance and airway response to methacholine: influence of body mass index. Can Respir J: 2005; 12 7 371 376 (Pubitemid 41748690)
120. Skloot G., Togias A. Bronchodilation and bronchoprotection by deep inspiration and their relationship to bronchial hyperresponsiveness. Clin Rev Allergy Immunol: 2003; 24 1 55 72
121. McCallister J. W., Parsons J. P., Mastronarde J. G. The relationship between gastroesophageal reflux and asthma: an update. Ther Adv Respir Dis: 2011; 5 2 143 150
122. Thomsen S. F., Duffy D. L., Kyvik K. O., Skytthe A., Backer V. Risk of asthma in adult twins with type 2 diabetes and increased body mass index. Allergy: 2011; 66 4 562 568
123. Lafond C., Sériès F., Lemière C. Impact of CPAP on asthmatic patients with obstructive sleep apnoea. Eur Respir J: 2007; 29 2 307 311 (Pubitemid 46231908)
124. Torchio R., Gobbi A., Gulotta C., et al. Mechanical effects of obesity on airway responsiveness in otherwise healthy humans. J Appl Physiol: 2009; 107 2 408 416
125. Lommatzsch M., Julius P., Virchow J. C. Tiotropium step-up therapy in asthma. N Engl J Med: 2011; 364 6 578, author reply 578-579